BioCentury
ARTICLE | Company News

PPD deal

October 10, 2011 7:00 AM UTC

Asset manager The Carlyle Group and private equity firm Hellman & Friedman will acquire CRO PPD for $33.25 per share in cash, or $3.9 billion. The price is a 30% premium to PPD's close of $25.66 on Se...